SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZILA--test for oral cancer?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Fleming who wrote (51)7/17/1996 9:21:00 PM
From: Julio P. Antelo   of 61
 
To all: OXYCAL back on table?

Has anyone heard or read anything about this subject? Acquisition of OXYCAL, a privately held company with promising technoloy for delivering vitamins and other nutrients in oral form, has been the subject of rumors linked to ZILA for years. At the beginning of this year, the subject was "definitely" off the table until after the company could get pass the FDA approval process for Ora Test.

Well, I am now seeing posts on AOL about this very subject and how much it is back on the table. No doubt that this acquisition could make ZILA a dandy little company. But frankly, I don't see how management could find the time to complete the BDTC deal, get past the FDA process, grow the OraTest business and do the OXYCAL deal. Maybe the days last 36 hours in Phoenix instead of 24 and maybe the company will surprise us again. If you have any info on this matter, please post. Regards to all. Julio
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext